Approved Symbol |
Approved Name |
Location |
Source |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
MAPK9 |
mitogen-activated protein kinase 9 |
5q35 |
Mapped by CNV |
WNT11 |
wingless-type MMTV integration site family, member 11 |
11q13.5 |
Mapped by significant region |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
14q11.2 |
Mapped by significant region |
WNT10A |
wingless-type MMTV integration site family, member 10A |
2q35 |
Mapped by significant region |
WNT6 |
wingless-type MMTV integration site family, member 6 |
2q35 |
Mapped by significant region |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
4q26 |
Mapped by CNV |
PLCB2 |
phospholipase C, beta 2 |
15q15 |
Mapped by PBA pathway |
APC |
adenomatous polyposis coli |
5q21-q22 |
Mapped by LD-proxy; Mapped by PBA pathway |
PPP2R5B |
protein phosphatase 2, regulatory subunit B', beta |
11q12 |
Mapped by significant region |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
11q23.1 |
Mapped by significant region |
CCND1 |
cyclin D1 |
11q13 |
Mapped by significant region |
FZD4 |
frizzled family receptor 4 |
11q14-q21 |
Mapped by significant region |
PPP3R2 |
protein phosphatase 3, regulatory subunit B, beta |
9q31 |
Mapped by significant region |
CACYBP |
calcyclin binding protein |
1q24-q25 |
Mapped by significant region |
PLCB3 |
phospholipase C, beta 3 (phosphatidylinositol-specific) |
11q13 |
Mapped by significant region |
LRP5 |
low density lipoprotein receptor-related protein 5 |
11q13.4 |
Mapped by CNV; Mapped by significant region |
FOSL1 |
FOS-like antigen 1 |
11q13 |
Mapped by significant region |
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
2p24 |
Mapped by significant region |